浏览全部资源
扫码关注微信
北京中医药大学 中药学院,北京 102488
Received:19 September 2022,
Published Online:21 October 2022,
Published:20 December 2022
移动端阅览
李娟,柳钰书,刘滢等.人参皂苷Rb1经鼻给药对戊四唑慢性点燃小鼠的抗癫痫作用[J].中国实验方剂学杂志,2022,28(24):65-74.
LI Juan,LIU Yushu,LIU Ying,et al.Effect of Intranasal Ginsenoside Rb1 Against Epilepsy in Mice Induced by Chronic Ignition of Pentylenetetrazole[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(24):65-74.
李娟,柳钰书,刘滢等.人参皂苷Rb1经鼻给药对戊四唑慢性点燃小鼠的抗癫痫作用[J].中国实验方剂学杂志,2022,28(24):65-74. DOI: 10.13422/j.cnki.syfjx.20221908.
LI Juan,LIU Yushu,LIU Ying,et al.Effect of Intranasal Ginsenoside Rb1 Against Epilepsy in Mice Induced by Chronic Ignition of Pentylenetetrazole[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(24):65-74. DOI: 10.13422/j.cnki.syfjx.20221908.
目的
2
观察人参皂苷Rb
1
经鼻给药的抗癫痫作用并对作用机制进行初探研究。
方法
2
采用小鼠戊四唑(PTZ)腹腔注射构建慢性癫痫模型,造模成功后(21 d)将癫痫小鼠随机分为PTZ组、丙戊酸钠(VPA)组、人参皂苷Rb
1
低、高剂量组(20、40 mg·kg
-1
)。各组小鼠分别经鼻给予相应药物30 d,每日2次,空白组经鼻给予等体积生理盐水。给药期间记录小鼠体质量变化、癫痫发作潜伏期、癫痫发作级别,远程无线记录动物脑电图(EEG)变化。采用神经元特异核蛋白(NeuN)观察大脑皮层及海马神经元损伤,采用离子钙结合衔接分子-1(IBA-1)、胶质纤维酸性蛋白(GFAP)分别观察小胶质细胞激活、星形胶质细胞活化现象。用谷氨酸(Glu)转运体-1(GLT-1)、谷氨酰胺合成酶(GS)观察Glu调节关键分子变化。
结果
2
与空白组比较,PTZ明显抑制小鼠体质量增加(
P
<
0.05,
P<
0.01),显著缩短癫痫发作潜伏期(
P<
0.01),显著升高癫痫发作最高级别(
P<
0.01),癫痫样脑电波增加。与PTZ组比较,人参皂苷Rb
1
低、高剂量组小鼠体质量增加(
P
<
0.05,
P<
0.01),癫痫发作潜伏期延长(
P
<
0.05,
P<
0.01),癫痫发作级别降低(
P
<
0.05,
P<
0.01),癫痫样脑电波减少。免疫荧光(IF)结果显示,人参皂苷Rb
1
治疗显著改善PTZ引起的小鼠大脑皮层运动感觉区及海马CA1区神经元损伤(
P
<
0.05,
P<
0.01),并明显抑制小胶质细胞激活(
P
<
0.05,
P<
0.01)、星形胶质细胞活化。进一步研究发现,人参皂苷Rb
1
治疗显著改善癫痫小鼠大脑星形胶质细胞GLT-1(
P
<
0.01)和GS表达(
P
<
0.01)。
结论
2
人参皂苷Rb
1
经鼻给药能显著改善PTZ引起的小鼠癫痫症状,对癫痫小鼠大脑神经元损伤具有明确保护作用,并能显著抑制癫痫小鼠大脑小胶质细胞激活和星形胶质细胞活化,其抗癫痫作用可能与调节星形胶质细胞Glu代谢关键分子GLT-1和GS有关。
Objective
2
To observe the effect of intranasal ginsenoside Rb
1
against epilepsy and preliminarily explore the mechanism.
Method
2
The mouse model of chronic epilepsy was established by intraperitoneal injection of pentylenetetrazole (PTZ). After successful modeling (21 d), the epileptic mice were randomly divided into PTZ group, sodium valproate (VPA) group, and low-dose (20 mg·kg
-1
) and high-dose (40 mg·kg
-1
) ginsenoside Rb
1
groups. Mice in each group were given corresponding drugs intranasally for 30 days, twice a day, and the control group was given the equal volume of normal saline. During the intranasal administration, the weight change, epilepsy latency, and epilepsy stage of the mice were recorded, and the changes in the electroencephalography (EEG) were recorded wirelessly. Neuronal Nuclei (NeuN) was used to observe the damage of neurons in cerebral cortex and hippocampus. The activation of microglia and astrocytes was observed with ionized calcium binding adapter molecule-1 (IBA-1) and glial fibrillary acidic protein (GFAP), respectively. Glutamate (Glu) transporter-1 (GLT-1) and glutamine synthetase (GS) were used to observe the key molecular changes in Glu regulation.
Result
2
Compared with the control group, the PTZ group decreased body weight (
P
<
0.05,
P
<
0.01), shortened the epilepsy latency (
P
<
0.01), and increased the epilepsy stage (
P
<
0.01). The epileptic EEG waves were increased in the PTZ group. Compared with the PTZ group, the low and high-dose ginsenoside Rb
1
groups increased body weight (
P
<
0.05,
P
<
0.01), prolonged the epilepsy latency (
P
<
0.05,
P
<
0.01), decreased the epilepsy stage (
P
<
0.05,
P
<
0.01), and decreased epileptiform EEG waves. Immunofluorescence staining (IF) showed that ginsenoside Rb
1
significantly ameliorated PTZ-induced neuronal damage (
P
<
0.05,
P
<
0.01) in the motor sensory area of the cerebral cortex and hippocampal CA1 area, and significantly inhibited PTZ-induced activation of microglia (
P
<
0.05,
P
<
0.01) and astrocytes. Further research found that ginsenoside Rb
1
significantly improved the expressions of astrocytic GLT-1 (
P
<
0.01) and GS (
P
<
0.01) in the brains of epileptic mice.
Conclusion
2
Intranasal ginsenoside Rb
1
can significantly improve the symptoms of epilepsy caused by PTZ in mice, which has a clear protective effect on neuronal damage in the brains of epileptic mice and significantly inhibits the activation of brain microglia and astrocyte activation. Its anti-epileptic mechanism may be related to the regulation of GLT-1 and GS of the key molecules of astrocyte Glu metabolism.
LöSCHER W , KLITGAARD H , TWYMAN R E , et al . New avenues for anti-epileptic drug discovery and development [J]. Nat Rev Drug Discov , 2013 , 12 ( 10 ): 757 - 776 .
NAGAI Y , JONES C I , SEN A . Galvanic skin response (GSR)/electrodermal/skin conductance biofeedback on epilepsy: A systematic review and meta-analysis [J]. Front Neurol , 2019 , 10 : 377 .
STEINHOFF B J , STAACK A M , HILLENBRAND B C . Randomized controlled antiepileptic drug trials miss almost all patients with ongoing seizures [J]. Epilepsy Behav , 2017 , 66 : 45 - 48 .
LöSCHER W , SCHMIDT D . Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma [J]. Epilepsia , 2011 , 52 ( 4 ): 657 - 678 .
余沛扬 . 关于人参治疗癫痫的探讨 [J]. 中医临床研究 , 2011 , 3 ( 14 ): 42 - 43 .
GUPTA Y K , SHARMA M , CHAUDHARY G . Antiepileptic activity of Panax ginseng against pentylenetetrazole induced kindling in rats [J]. Indian J Physiol Pharmacol , 2001 , 45 ( 4 ): 502 - 506 .
HAYASHI M K . Structure-function relationship of transporters in the glutamate-glutamine cycle of the central nervous system [J]. Int J Mol Sci , 2018 , doi: 10.3390/ijms19041177 http://dx.doi.org/10.3390/ijms19041177 .
CHAUDHRY F A , LEHRE K P , VAN LOOKEREN C M , et al . Glutamate transporters in glial plasma membranes:Highly differentiated localizations revealed by quantitative ultrastructural immunocytoch-emistry [J]. Neuron , 1995 , 15 ( 3 ): 711 - 720 .
GRAS G , PORCHERAY F , SAMAH B , et al . The glutamate-glutamine cycle as an inducible, protective face of macrophage activation [J]. J Leukoc Biol , 2006 , 80 ( 5 ): 1067 - 1075 .
ROSE C F , VERKHRATSKY A , PARPURA V . Astrocyte glutamine synthetase: Pivotal in health and disease [J]. Biochem Soc Trans , 2013 , 41 ( 6 ): 1518 - 1524 .
KIM K H , LEE D , LEE H L , et al . Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: Past findings and future directions [J]. J Ginseng Res , 2018 , 42 ( 3 ): 239 - 247 .
CHEN Z , LU T , YUE X , et al . Neuroprotective effect of ginsenoside Rb 1 on glutamate-induced neurotoxicity: With emphasis on autophagy [J]. Neurosci Lett , 2010 , 482 ( 3 ): 264 - 268 .
XIE W , WANG X , XIAO T , et al . Protective effects and network analysis of ginsenoside Rb 1 against cerebral ischemia injury: A pharmacological review [J]. Front Pharmacol , 2021 , 12 : 604811 .
YANG F , MA Q , MATSABISA M G , et al . Panax notoginseng for cerebral ischemia: A systematic review [J]. Am J Chin Med , 2020 , 48 ( 6 ): 1331 - 1351 .
AHMED T , RAZA S H , MARYAM A , et al . Ginsenoside Rb 1 as a neuroprotective agent: A review [J]. Brain Res Bull , 2016 , 125 : 30 - 43 .
SHI Y , MIAO W , TENG J , et al . Ginsenoside Rb 1 protects the brain from damage induced by epileptic seizure via Nrf2/ARE signaling [J]. Cell Physiol Biochem , 2018 , 45 ( 1 ): 212 - 225 .
ZENG X , HU K , CHEN L , et al . The effects of ginsenoside compound k against epilepsy by enhancing the γ -aminobutyric acid signaling pathway [J]. Front Pharmacol , 2018 , 9 : 1020 .
苏元元 , 付宇 , 李楠楠 , 等 . 三种达玛烷型皂苷的生物药剂学分类及吸收机制研究 [J]. 中国现代中药 , 2018 , 20 ( 9 ): 1150 - 1156 .
武伦鹏 , 白龙律 , 韩春峰 , 等 . 微生物转化人参主要皂苷Rb 1 为C-K的研究 [J]. 人参研究 , 2016 , 28 ( 2 ): 7 - 11 .
NIU T , SMITH D L , YANG Z , et al . Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing [J]. Pharm Res , 2013 , 30 ( 3 ): 836 - 846 .
AL-KASSAS R , BANSAL M , SHAW J . Nanosizing techniques for improving bioavailability of drugs [J]. J Control Release , 2017 , 260 : 202 - 212 .
VERONESI M C , ALHAMAMI M , MIEDEMA S B , et al . Imaging of intranasal drug delivery to the brain [J]. Am J Nucl Med Mol Imaging , 2020 , 10 ( 1 ): 1 - 31 .
MIGNANI S , SHI X , KARPUS A , et al . Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs [J]. Eur J Med Chem , 2021 , 209 : 112905 .
王浩 , 邹茜 . 人参皂苷Rg 1 调节沉默信息调节因子1对抗晶状体上皮细胞衰老的影响 [J]. 世界中医药 , 2021 , 16 ( 7 ): 1095 - 1098 .
SHIMADA T , YAMAGATA K . Pentylenetetrazole-Induced kindling mouse model [J]. J Vis Exp , 2018 , doi: 10.3791/56573 http://dx.doi.org/10.3791/56573 .
HANSON L R , FINE J M , SVITAK A L , et al . Intranasal administration of CNS therapeutics to awake mice [J]. J Vis Exp , 2013 , 74 : 4440 .
VAN ERUM J , VAN DAM D , DE DEYN P P . PTZ-induced seizures in mice require a revised Racine scale [J]. Epilepsy Behav , 2019 , 95 : 51 - 55 .
ZAYACHKIVSKY A , LEHMKUHLE M J , DUDEK F E . Long-term continuous EEG monitoring in small rodent models of human disease using the epoch wireless transmitter system [J]. J Vis Exp , 2015 ( 101 ): e52554 .
国家药典委员会 . 中华人民共和国药典 [M]. 北京 : 中国医药科技出版社 , 2020 .
曾祥昌 , 周露萍 , 陈露露 , 等 . 人参皂苷C-K对匹罗卡品致痫大鼠发作的影响 [J]. 中国临床药理学与治疗学 , 2017 , 22 ( 2 ): 139 - 143 .
吴成举 , 陈靖 , 谢鑫 , 等 . 人参皂苷Rb 1 对癫痫大鼠海马神经元的影响 [J]. 北方药学 , 2013 , 10 ( 2 ): 41 - 42 .
甄军丽 , 常迎娜 , 付涛 , 等 . 人参皂苷Rb 1 对癫痫大鼠海马组织线粒体的保护作用和机制探讨 [J]. 脑与神经疾病杂志 , 2016 , 24 ( 3 ): 148 - 152 .
陈雪 , 张慧明 , 马青 , 等 . 人参皂苷Rb 1 治疗性给药的抗癫痫作用及机制研究 [J]. 西北药学杂志 , 2021 , 36 ( 5 ): 739 - 745 .
LU T , JIANG Y , ZHOU Z , et al . Intranasal ginsenoside Rb 1 targets the brain and ameliorates cerebral ischemia/reperfusion injury in rats [J]. Biol Pharm Bull , 2011 , 34 ( 8 ): 1319 - 1324 .
MASON C R , COOPER R M . A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazol [J]. Epilepsia , 1972 , 13 ( 5 ): 663 - 674 .
刘小虎 , 向绍杰 , 齐越 , 等 . 戊四唑急性癫痫模型海马病理组织的变化 [J]. 中国药理学通报 , 2015 ( 4 ): 514 - 517,518 .
CATALE C , GIRONDA S , LO IACONO L , et al . Microglial function in the effects of early-life stress on brain and behavioral development [J]. J Clin Med , 2020 , 9 ( 2 )
THERAJARAN P , HAMILTON J A , O'BRIEN T J , et al . Microglial polarization in posttraumatic epilepsy: Potential mechanism and treatment opportunity [J]. Epilepsia , 2020 , 61 ( 2 ): 203 - 215 .
宋维强 . 小胶质细胞与癫痫的关系研究进展 [J]. 中国临床神经外科杂志 , 2019 , 24 ( 5 ): 314 - 316 .
PATEL D C , TEWARI B P , CHAUNSALI L , et al . Neuron-glia interactions in the pathophysiology of epilepsy [J]. Nat Rev Neurosci , 2019 , 20 ( 5 ): 282 - 297 .
袁旭 , 李政 , 王晓天 , 等 . 中药及其有效成分在抗癫痫中的作用与机制 [J]. 中国中药杂志 , 2019 , 44 ( 1 ): 9 .
BEGHI E . The Epidemiology of epilepsy [J]. Neuroepidemiology , 2020 , 54 ( 2 ): 185 - 191 .
LANGE F , HöRNSCHEMEYER J , KIRSCHSTEIN T . Glutamatergic mechanisms in glioblastoma and tumor-associated epilepsy [J]. Cells , 2021 , 10 ( 5 ): 134 .
陈雪 , 马青 , 张慧明 , 等 . 星形胶质细胞调控的谷氨酸代谢与癫痫的关系探讨 [J]. 生理科学进展 , 2022 , 53 ( 2 ): 127 - 131 .
BORGES K , MCDERMOTT D , IRIER H , et al . Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus [J]. Exp Neurol , 2006 , 201 ( 2 ): 416 - 427 .
0
Views
23
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution